IMM 0.00% 34.0¢ immutep limited

nasdaq is overdue and an explanation is reqd

  1. 1,485 Posts.
    I think it's been about 16 months (from memory) that we were told that an application to list on the NASDAQ had been submitted. I know there were accounting standards we had to comply with, and I know the company was advised not to discuss the listing while it was pending.

    But at this point in time, I feel the delays are excessive, and my gut tells me there are other undisclosed problems or obstacles. Surely 16 months is long enough for investors to be kept hanging. If there are problems with the process, or further issues of complience, we deserve to know what these are. Investors are hanging back, and the occasional good announcement on sales, marketing, infrastructure, clinical test and patents are having no effect on the price.

    How about something, anything at all, on the NASDAQ? Institutional investors would certainly be asking these questions - why can't we?
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.000(0.00%)
Mkt cap ! $493.8M
Open High Low Value Volume
34.5¢ 35.0¢ 33.5¢ $724.1K 2.106M

Buyers (Bids)

No. Vol. Price($)
3 60483 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 55452 4
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.